PDS Biotech hosts virtual KOL event on PDS0301 in advanced colorectal cancer with liver metastases
Bitget2026/10/06 12:07PDS Biotech will host a virtual KOL event on Oct. 15, 2026 at 8:00 a.m. ET. Discussion will center on Phase 2 clinical outcomes for PDS0301 in advanced liver-associated cancers, highlighting metastatic colorectal cancer. Program will cover second- and third-line unresectable MSS or pMMR colorectal liver metastases, a setting where immunotherapy has largely underperformed. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PDS Biotechnology Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610060800PRIMZONEFULLFEED9840213) on October 06, 2026, and is solely responsible for the information contained therein.
- PDS Biotech will host a virtual KOL event on Oct. 15, 2026 at 8:00 a.m. ET.
- Discussion will center on Phase 2 clinical outcomes for PDS0301 in advanced liver-associated cancers, highlighting metastatic colorectal cancer.
- Program will cover second- and third-line unresectable MSS or pMMR colorectal liver metastases, a setting where immunotherapy has largely underperformed.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem
Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.

